今年上半年，我国西药类产品出口额为140亿美元，同比增长了6.55%，增幅较去年同期缩水20.5%；进口额为96.1亿美元，虽然保持了20%以上的增长，但与去年接近40%的增速相比仍相差甚远。

In the first half of this year，Our country western medicine products exports to 14 billion us dollars，Growth of 6.55% year-on-year，Growth shrink 20.5% compared to the same period last year；Amount of imports for 9.61 billion dollars，Although keep more than 20% growth，But last year and nearly 40% of the growth is still a far cry from what compared。

　　当前，国际经济整体萎靡，欧债危机日趋严重，失业率居高不下，市场上供大于求的矛盾逐渐凸显。受此影响，今年上半年，我国西药类产品出口增速明显放缓，特别是在3、4月份，出口额和出口量同比均出现负增长，至5月份以后，出口增速持续下降的趋势才有所缓解。

The current，International economic integral sag，The debt crisis become more and more serious，High unemployment，Market the contradiction of supply over demand are becoming sharper and sharper。Affected by this，In the first half of this year，Our country western medicine products marked slowdown in export growth，Especially in 3、In April，Year-on-year exports and export all appear negative growth，To 5 months later，Export growth continued to decline trend just to ease。

　　今年上半年，我国西药类产品外贸增长趋缓。根据中国海关数据统计，1～6月份，我国西药类产品进出口总额为236亿美元，同比增长了12.11%，增幅比2011年1～6月的31.19%下降了19.08%。

In the first half of this year，Western medicine products in our country foreign trade growth to slow down。According to China's customs statistics，1 ~ 6 months，Our country western medicine products import and export amount of $23.6 billion，Growth of 12.11% year-on-year，Growth than in 2011 1 ~ 6 months of 31.19% 19.08%。

　　其中，西药类产品出口额为140亿美元，同比增长了6.55%，增幅较去年同期有较大缩水，下降了20.5%；进口额为96.1亿美元，同比增长虽然保持在20%以上，但与去年同期接近40%的增速相比仍相差甚远。今年上半年，我国西药类产品贸易顺差进一步收窄至43.9亿美元，同比下降了15.89%。

the，Western medicine products exports to 14 billion us dollars，Growth of 6.55% year-on-year，Compared to the same period last year growth has great shrink，Dropped 20.5%；Amount of imports for 9.61 billion dollars，Year-on-year growth although to stay above 20%，But with the same period last year growth of close to 40% of the compared is still a far cry from what。In the first half of this year，Our country western medicine products further trade surplus narrowed to $4.39 billion，A 15.89% decline from a year earlier。

　　预计今年下半年，我国西药类产品进出口结构转型态势将日趋明显。从进口方面看，随着我国政府用于医疗保健体系的资金不断增加，人民消费水平不断提高，我国对进口药品的需求也将随之增长。同时，政府出台政策鼓励“扩大进口”，促进消费的同时，也将持续促进药品进口，因此，我国西药类产品进口规模将继续攀升。

Expected the second half of this year，Our country western medicine products import and export structure transformation situation will become increasingly obvious。From the import side to see，Along with our country government used for medical and health care system of increasing capital，People's consumption level continuously improve，For the demand of our country imported drugs will grow。At the same time，The government policy to encourage“Expand import”，Promote consumption at the same time，Also will continue to promote the imported drugs，therefore，Our country western medicine products import scale will continue to rise。

　　而出口市场则不容乐观，由于国际宏观经济形势整体未见向好，市场需求匮乏将导致国内以出口为主的产品产能趋于过剩。因此，我国西药类产品出口有可能进入增长“平台期”甚至陷入增长“停滞期”。短期来看，化学原料药仍然为出口的主力军，但出口增长点已经转移到西成药和生化药上，并且随着政策的引导和市场的进一步调节，这一趋势将越来越明晰。相信在不断创新的基础上，未来，我国西成药和生化药将在国际医药市场上大有作为，而这也将使我国屹立于世界制药强国之林，并在世界医药产业格局中占据更为重要的地位。

And export market is not optimistic，The international macro economic situation did not see the whole is going well，Lack of market demand will lead to domestic export-oriented products tend to excess production capacity。therefore，Our country western medicine products export may enter the growth“Platform period”Even in growth“Lag phase”。Short term，Chemical API for export is still the main force，But export growth have been transferred to the west medicine and biochemical medicine on，And along with the policy guidance and market further adjustment，This trend will more and more clear。Believe in constant on the foundation of innovation，The future，China west medicine and biochemical medicine will in the international medical market as much，And this will make our country political standing in the world pharmaceutical power，And on the world medicine industry structure has more important position。

　　出口：大洋洲非洲市场耀眼

export：Oceania Africa market dazzling

　　产品格局没有太大变化，化学原料药以82.99%的占比稳坐“老大”位置

Product structure not too big change，With 82.99% of the chemical API of stability than sit“boss”position

　　2012年上半年，我国西药类产品对亚洲和欧洲传统市场的出口额增速缓慢，仅为4.85%和1.63%；对北美洲出口则受出口均价上涨带动，增加至21.5亿美元，同比增长16.97%；对大洋洲、非洲出口额同比增速更是令人眼前一亮，分别夺得增长44.36%、14.29%的佳绩。虽然目前我国西药类产品对大洋洲和非洲这两个市场的出口规模还很小，但这两大市场对西药类产品的需求增长很快且未来潜力巨大，非常值得业内关注。

In the first half of 2012，Our country western medicine products to Asia and Europe market traditional exports slow growth，Only 4.85% and 1.63%；Export to North America by average prices in the export drive，Increased to $2.15 billion，Year-on-year growth of 16.97%；To Oceania、African exports year-on-year growth is a shine at the moment，Won respectively increased by 44.36%、14.29% of success。Although at present our country western medicine products to Oceania and Africa, the two market export scale is very small，But the two big market for western medicine products demand is growing rapidly and great potential for future，Very worth attention in the industry。